Sigma-Aldrich Buys BioReliance from Avista

Sigma-Aldrich Corp. is paying $350 million in cash to buy biopharmaceutical testing services provider Rockville, Maryland-based BioReliance Holdings Inc. from Avista Capital Partners, Reuters reported Monday. The deal is expected to close in the first quarter of this year.

DealsNorth AmericaUSBriefs